Unadjusted and adjusted OR for pain. * Pain was measured on a 0–10 numeric rating score. Pain scores were dichotomized as ≤ 2 or > 2, based on the median score for the cohort. Data in bold type indicate p < 0.05.
| Patient- or Proxy-reported Pain | |||
|---|---|---|---|
| African American* | Asian* | Hispanic or Latino** | |
| Unadjusted OR (95% CI) | 1.6 (1.2–2.1) | 0.4 (0.2–0.7) | 1.4 (1.1–1.7) |
| Adjusted OR (95% CI) | |||
| Age at disease onset, disease duration, sex | 1.2 (0.8–1.7) | 0.3 (0.2–0.5) | 1.3 (1.1–1.6) |
| + Socioeconomic statusa | 1.2 (0.9–1.6) | 0.4 (0.2–0.7) | 1.2 (0.9–1.5) |
| + Disease characteristicsb | 1.1 (0.7–1.7) | 0.2 (0.1–0.5) | 1.1 (0.9–1.5) |
| + Treatmentc | 1.1 (0.7–1.7) | 0.2 (0.1–0.6) | 1.1 (0.9–1.5) |
↵* Whites as referent group;
↵** non-Hispanics and non-Latinos as referent group. Each group of variables was added to the logistic regression model in the sequence indicated above. Groups consisted of the following variables:
↵a income; insurance status.
↵b JIA category (oligoarthritis, polyarthritis, systemic); rheumatoid factor status; physician global assessment of disease activity; active joint count.
↵c Current or past treatment with a nonbiologic disease-modifying antirheumatic drug (DMARD); current or past treatment with a biologic DMARD. JIA: juvenile idiopathic arthritis.